MASEP MEDICAL SCIENCE & TECHNOLOGY DEVELOPMENT (SHENZHEN) CO. LTD. – Trademark Portfolio
Entity Type: 99
MASEP MEDICAL SCIENCE & TECHNOLOGY DEVELOPMENT (SHENZHEN) CO. LTD. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include MASEP. The owner is based in NANSHAN, SHENZHEN.
ROOM 601, BUILDING NO.14
NANSHAN, SHENZHEN 518000 , CN
Showing of trademarks Trademarks
Trademark Classifications
MASEP MEDICAL SCIENCE & TECHNOLOGY DEVELOPMENT (SHENZHEN) CO. LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Frequently Asked Questions
How many trademarks does MASEP MEDICAL SCIENCE & TECHNOLOGY DEVELOPMENT (SHENZHEN) CO. LTD. have?
MASEP MEDICAL SCIENCE & TECHNOLOGY DEVELOPMENT (SHENZHEN) CO. LTD. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does MASEP MEDICAL SCIENCE & TECHNOLOGY DEVELOPMENT (SHENZHEN) CO. LTD. file in?
MASEP MEDICAL SCIENCE & TECHNOLOGY DEVELOPMENT (SHENZHEN) CO. LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are MASEP MEDICAL SCIENCE & TECHNOLOGY DEVELOPMENT (SHENZHEN) CO. LTD.'s most well-known trademarks?
MASEP MEDICAL SCIENCE & TECHNOLOGY DEVELOPMENT (SHENZHEN) CO. LTD.'s registered trademark portfolio includes well-known marks such as MASEP. These are among 1 currently registered trademark in the portfolio.
What is MASEP MEDICAL SCIENCE & TECHNOLOGY DEVELOPMENT (SHENZHEN) CO. LTD.'s trademark registration success rate?
MASEP MEDICAL SCIENCE & TECHNOLOGY DEVELOPMENT (SHENZHEN) CO. LTD. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.